BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Rensselaer Polytechnic Institute Researcher Secures $1.4 Million National Institutes of Health (NIH) Grant To Enable Faster Cancer Radiation Treatment Planning


5/27/2010 11:23:49 AM

Rensselaer Polytechnic Institute Professor Richard Radke is leading a new $1.4 million study to develop novel computer automation techniques that could reduce the prep time of a promising cancer-treatment technology from several hours to a few minutes.

This promising method, called intensity-modulated radiation therapy (IMRT), is extremely effective for treating cancer. Pioneered by the Memorial Sloan-Kettering Cancer Center in 1996, IMRT delivers non-uniform doses of radiation from different angles to a tumor site, and enables a high dose to be delivered to a tumor while at the same time delivering a low dose to nearby healthy tissue.

Creating an acceptable IMRT plan, however, requires several hours of preparatory trial-and-error adjustments and optimizations to ensure the radiation administered to the tumor does not impact surrounding healthy tissue. Radke is working to simplify and automate this optimization process, which currently requires an expert human technician to manually adjust many parameters in order to best accomplish the physician’s goals and specifications.

Collaborating with colleagues at the Memorial Sloan-Kettering Cancer Center, Radke and his graduate students had previously created and successfully demonstrated effective algorithms for automating the optimization of IMRT for prostate cancer, trimming the computational prep time down to five minutes using a standard desktop computer. In this new four-year, $1.4 million study, funded by the U.S. National Institutes of Health National Cancer Institute, Radke will adapt his approach, called Reduced-Order Constrained Optimization (ROCO), to IMRT treatment of tumors in the lung, head, and neck.

“For IMRT and similar new technologies to reach their full potential as life-saving tools for treating cancer, it is critical to reduce planning times down to a matter of minutes. This is the challenge we are going to tackle in our new NIH-funded study,” said Radke, associate professor in the Department of Electrical, Computer, and Systems Engineering at Rensselaer. “In the longer term, we believe our proposed approach will provide deeper insight into the science of radiation dose optimization, and reduce both the subjectivity and trial-and-error aspect of radiation therapy treatment plan selection.”

The new study is titled “Reduced-Order Constrained Optimization for Rapid IMRT and VMAT Treatment Planning.” Extending the techniques Radke’s team developed for the prostate to treat tumors in the lung, head, or neck presents a challenge, since in the latter sites many healthy, radiation-sensitive tissues are typically clustered near tumors. A further challenge is adapting ROCO to the even more advanced technology of Volumetric-Modulated Arc Therapy (VMAT), in which radiation is continuously delivered to the patient in a smooth arc instead of at a few discrete positions.

As part of the new study, Radke will work with researchers at Memorial Sloan-Kettering Cancer Center to integrate the ROCO tools into the center’s clinical treatment planning system, to refine and test the optimization improvements in an experimental, real-world setting.

Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->